Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.65 CAD | 0.00% | -10.74% | -9.46% |
Apr. 16 | KITS Eyecare Ltd. Announces Executive Appointments | CI |
Apr. 10 | Kits Eyecare Announces Sabrina Liak Will Transition to Senior Advisor Role and Continue as Board Member | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Other Specialty Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.46% | 129M | - | ||
-15.29% | 1.39B | C | ||
+14.19% | 726M | - | ||
-28.51% | 516M | - | ||
-21.23% | 376M | - | ||
+23.66% | 190M | - | - | |
-22.76% | 132M | - | - | |
-9.67% | 100M | - | ||
+0.33% | 92.65M | - | - | |
+1.41% | 69.63M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- KITS Stock
- Ratings Kits Eyecare Ltd.